Lymphoma models for B-cell activation and tolerance
- 1 August 1988
- journal article
- research article
- Published by Elsevier in Cellular Immunology
- Vol. 115 (1) , 195-203
- https://doi.org/10.1016/0008-8749(88)90173-6
Abstract
No abstract availableThis publication has 27 references indexed in Scilit:
- Interaction of oncodazole (R 17934), a new anti-tumoral drug, with rat brain tubulinPublished by Elsevier ,2004
- Role of T Cell‐Derived Lymphokines in Two Models of B‐Cell ToleranceImmunological Reviews, 1987
- Lymphoma models for B cell activation and tolerance. III. Cell cycle dependence for negative signalling of WEHI-231 B lymphoma cells by anti-mu.The Journal of Experimental Medicine, 1986
- Lymphoma models for B cell activation and tolerance IV. Growth inhibition by anti‐Ig of CH31 and CH33 B lymphoma cellsEuropean Journal of Immunology, 1986
- Lymphoma models for B-cell activation and toleranceCellular Immunology, 1985
- Significant non-S-phase DNA synthesis visualized by flow cytometry in activated and in malignant human lymphoid cellsExperimental Cell Research, 1985
- Isoquinolinesulfonamides, novel and potent inhibitors of cyclic nucleotide-dependent protein kinase and protein kinase CBiochemistry, 1984
- Activation and proliferation signals in mouse B cells I. A comparison of the capacity of anti‐Ig antibodies or phorbol myristic acetate to activate B cells from CBA/N or normal mice into G1European Journal of Immunology, 1984
- Use of Monoclonal Anti-mouse Immunoglobulin to Detect Mouse AntibodiesHybridoma, 1981
- Stimulation of mouse lymphocytes by insoluble anti-mouse immunoglobulinNature, 1975